UCLA Journal of Radiation Oncology FALL 2024 and ANNUAL REPORT - Flipbook - Page 40
WHAT OUR
PATIENTS
ARE SAYING
" A t 7 4 y e a r s o l d , I w a s d i a g n o s e d w i t h l o w - m i d g r a d e p r o s t a t e c a n c e r.
A f t e r e x t e n s i v e r e s e a r c h r e g a r d i n g t h e t r e a t m e n t o f p r o s t a t e c a n c e r, a n d
e v e n t h o u g h I l i v e i n Te x a s , I s e l e c t e d t h e r a d i a t i o n t r e a t m e n t p r o v i d e d
b y U C L A - H e a l t h . T h e y u t i l i z e d t h e M R I d i a n a c c e l e r a t o r b y V i e w r a y.
S t a r t i n g w i t h D r. K i s h a n , h i s s t a ff , a n d t h e r a d i a t i o n t e c h s . . . e v e r y o n e
w a s p r o f e s s i o n a l , k n o w l e d g e a b l e , a n d f r i e n d l y. I w o u l d g i v e t h e m a l l
10 stars, if that was an option. My treatments began in October 2023,
a n d 8 m o n t h s l a t e r, I h a v e h a d l i t t l e o r n o s i d e e ff e c t s . T h a n k y o u a l l
v e r y, v e r y m u c h f o r y o u r e x c e l l e n t c a r e . " - J i m
